Pharmacokinetics Of Orally Administered Fx-1006A In Subjects With Hepatic Dysfunction

Clinical trial NCT01358565 · COMPLETED

Trial details

NCT number: NCT01358565
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Mild Hepatic Dysfunction Moderate Hepatic Dysfunction

Start date: 2010-11-01
Primary completion: 2011-04-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.